- Work/Life Balance
- Culture & Values
- Career Opportunities
- Comp & Benefits
- Senior Management
I worked at Nuvelo full-time (More than 5 years)RecommendsNeutral OutlookApproves of CEORecommendsNeutral OutlookApproves of CEO
A company that cares about it's employees
Deadlines are unreasonable, acquisition inevitable.
Advice to Management
Hirer more qualified staff
Let us know if we're missing any workplace or industry recognition –
Nuvelo is hunting for new ways to treat acute medical conditions. Its pipeline consists of two product candidates in clinical development: anticoagulant NU172 and cell growth stimulator NU206. The company shifted gears and refocused itself after the disappointing failure of another candidate. Nuvelo is also conducting research on monoclonal antibodies to identify potential drugs to treat leukemia, acute cardiovascular disease and cancer. Nuvelo has agreed to merge with privately-held ARCA biopharma. The merger will bring ARCA's commercialization experience to the table as...